Adverum Biotechnologies Provides Program Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
November 2, 2018 9:05 AM EDTChardan Capital Markets analyst Gbola Amusa lowered the price target on Adverum Biotechnologies (NASDAQ: ADVM) to $4.50 (from $8.00) while maintaining a Neutral rating.
... MoreSunTrust Robinson Humphrey Downgrades Adverum Biotechnologies (ADVM) to Hold
November 2, 2018 6:23 AM EDTSunTrust Robinson Humphrey analyst Edward Nash downgraded Adverum Biotechnologies (NASDAQ: ADVM) from Buy to Hold with a price target of $4.00 (from $11.00).
Nash said they were surprised ADVM-043 is being discontinued due to lack of efficacy. Further, he highlights the company's second gene... More
